Market Overview:
The global 50% dextrose injection market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of diabetes, rising demand for minimally invasive surgeries, and growing number of outpatient procedures. By type, the 20ml segment is expected to account for the largest share of the global 50% dextrose injection market in 2018. This segment is also projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. By application, hospitals are expected to account for the largest share of the global 50% dextrose injection market in 2018. This segment is also projected to grow at a CAGR of 5.7%.
Product Definition:
A 50% dextrose injection is a medical solution that contains a 50% concentration of dextrose. This injection is used to treat low blood sugar levels, also known as hypoglycemia. The high sugar content in the solution helps to quickly raise blood sugar levels and restore normal function.
20ml:
20ml is a standard injection for 50% dextrose used in hospital and clinical settings. It's usage has been around since the 70s, but it was only recently that there has been any significant growth in its usage. The primary factor responsible for this change is the advent of 20/20 (dextrose-water) Injection which serves as an effective alternative to traditional 20ml dextrose injection.
40ml:
40ml is a measure containing 40 minims (0.0016 US fluid ounce) of pure dextrose in a water-soluble container. It is used as an ingredient in the preparation of various injections for intravenous and oral consumption, including the 50% dextrose injection which has been widely used to treat hypoglycemia since its introduction in 1982.
Application Insights:
The hospital application segment accounted for the largest revenue share of over 60% in 2017. The product is used as a general anesthetic and analgesic agent in surgical procedures. It also finds applications as an antidiabetic agent, which helps control blood sugar levels in patients suffering from diabetes mellitus type 2 or other chronic diseases of the pancreas such as insulin dependent diabetes mellitus (IDDM).
Dextrose 50% is used to treat hypoglycemia caused due to its ability to stimulate the liver cells responsible for breaking down stored fat into usable energy. It can be given by vein, via catheter or by mouth and is available in different sizes including 20ml, 40ml and 50ml bottles. The recovery center application segment was valued at USD 21 million in 2017 owing to increasing awareness regarding substance abuse among adults resulting in increased admissions at rehabilitation centers across the world.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of Dextrose Injection manufacturers and suppliers. The region is expected to maintain its dominance over the forecast period as well. This can be attributed to increasing R&D activities for new product development, high healthcare expenditure, and rising prevalence of obesity & diabetes in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving economic conditions, growing population along with an increase in healthcare spending by governments & private sectors especially due to rising incidence diabetes and obesity rates are also contributing towards regional growth. Moreover, increasing demand for insulin injections dueb/t rapidly developing medical tourism industry will drive regional demand further.
Growth Factors:
- Increasing incidence of diabetes: The increasing incidence of diabetes is the major growth driver for 50% Dextrose Injection market. According to the World Health Organization (WHO), the number of people with diabetes has almost quadrupled since 1980 and as of 2014, there were 422 million people living with diabetes. This number is expected to reach 642 million by 2040. This will create a large pool of patients who will require 50% Dextrose Injection for treatment and fueling the growth of this market.
- Rising demand for homecare: There is a rising demand for homecare due to increasing preference for convenience and comfort, growing geriatric population, and rising healthcare costs. This is driving the growth of 50% Dextrose Injection market as it can be administered at home without any need for hospitalization or special equipment or facilities.
- Technological advancements in delivery devices: There have been significant advancements in delivery devices such as pen injectors that are making administration of drugs easier, faster, and more accurate thereby fueling the growth of 50% Dextrose Injection market . These advancements are also helping to reduce side effects associated with drug administration thus widening its adoption among patients..
Scope Of The Report
Report Attributes
Report Details
Report Title
50% Dextrose Injection Market Research Report
By Type
20ml, 40ml, 50ml
By Application
Hospital, Clinics, Recovery Center
By Companies
Amphastar, Pfizer, Abbott, Baxter, Cisen Pharmaceutical, Medisan, Tafong Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
166
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global 50% Dextrose Injection Market Report Segments:
The global 50% Dextrose Injection market is segmented on the basis of:
Types
20ml, 40ml, 50ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amphastar
- Pfizer
- Abbott
- Baxter
- Cisen Pharmaceutical
- Medisan
- Tafong Pharmaceutical
Highlights of The 50% Dextrose Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 20ml
- 40ml
- 50ml
- By Application:
- Hospital
- Clinics
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the 50% Dextrose Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
50% Dextrose Injection is a type of medication that is used to treat low blood sugar. It helps to restore the body's normal blood sugar levels by providing glucose.
Some of the key players operating in the 50% dextrose injection market are Amphastar, Pfizer, Abbott, Baxter, Cisen Pharmaceutical, Medisan, Tafong Pharmaceutical.
The 50% dextrose injection market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 50% Dextrose Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 50% Dextrose Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 50% Dextrose Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the 50% Dextrose Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global 50% Dextrose Injection Market Size & Forecast, 2020-2028
4.5.1 50% Dextrose Injection Market Size and Y-o-Y Growth
4.5.2 50% Dextrose Injection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 20ml
5.2.2 40ml
5.2.3 50ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global 50% Dextrose Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 50% Dextrose Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 20ml
9.6.2 40ml
9.6.3 50ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 20ml
10.6.2 40ml
10.6.3 50ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 20ml
11.6.2 40ml
11.6.3 50ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 20ml
12.6.2 40ml
12.6.3 50ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 20ml
13.6.2 40ml
13.6.3 50ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 50% Dextrose Injection Market: Competitive Dashboard
14.2 Global 50% Dextrose Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Amphastar
14.3.2 Pfizer
14.3.3 Abbott
14.3.4 Baxter
14.3.5 Cisen Pharmaceutical
14.3.6 Medisan
14.3.7 Tafong Pharmaceutical
